Early Developmental Screening as a Risk Filter: What It Offers Health Insurers, Brokers and Corporate Clients

Standard health insurance packages have become a crowded, low-margin market. For an insurance broker (a Makler in Germany, an agent ubezpieczeniowy in Poland) and for a corporate HR director, two offers with similar tariffs look almost identical on paper. Price competition erodes the margin, and the product itself says little about how the insured population will actually behave over the next decade.

Risk management offers a different angle. Insurers have always worked by identifying risks early and reducing the cost of the ones that can be influenced. Child development is one of the few areas where a cheap, early and non-invasive intervention can plausibly change what happens years later, both in the insurer’s claims and in the employer’s payroll.

This article looks at early developmental screening of children from one to six years old as a risk filter. It asks what such a tool gives an underwriter, a broker and an employer, and where its limits lie. The figures quoted below are the working estimates used in the market discussion around the OkiTalki programme; they should be treated as planning assumptions to be verified on a specific portfolio, not as guarantees.

I. Why a standard package no longer differentiates

When every competitor offers a comparable list of benefits, a broker is left with two levers: price and service. Both are easy to copy. A measurable risk-management element changes the conversation, because the client compares outcomes instead of tariffs.

This is where a unique value proposition comes from in practice. It is not a discount and not an extra voucher. It is a mechanism that reduces expected losses for the insurer and expected absence for the employer, and that parents will actually use because it is quick, clear and free of stigma. For a broker, the task is therefore not to “sell” a novelty but to explain the mechanism in the language of loss ratio and workforce stability.

II. Direct medical costs: the loss ratio argument

The first effect is on direct medical claims. Many sensory and motor difficulties in young children are small at the age of two or three: a slightly weaker sense of balance, immature coordination, a delay in how the hands and eyes work together. At that stage they are cheap to address, usually through simple daily exercises at home.

If they are left unnoticed, the same difficulties tend to surface at school age and are then treated by expensive specialists: neurologists, psychiatrists, physiotherapists. The estimate used here is that early correction of sensorimotor deficits, at a cost of 24 € per child per year, can prevent substantial specialist expenses in the age range of 7–12 years.

For an underwriter, the logic is familiar from other preventive programmes. A small, predictable and early expense is set against a larger, uncertain and late one. The loss ratio improves not because fewer children are ill, but because fewer problems reach the stage where they require costly treatment. The effect is delayed by years, which is why it must be modelled on a cohort rather than expected in the next quarter.

III. Indirect corporate losses: worry, presenteeism and sick leave

The second effect is less obvious and, for a corporate client, often more tangible. A working parent who is anxious about a child’s development is not fully present at work. The worry is rarely dramatic: it is a constant background question of whether this is normal and whether something is being missed.

The market estimate is that a mother or father in this state can lose up to 40% of productivity. This is presenteeism: the employee is at the desk, but attention and energy are elsewhere. Alongside it comes absence. Appointments, searches for a specialist and sleepless nights translate into regular sick leave.

Uncertainty drives parental burnout more than the problem itself: a parent with a clear picture of the child’s development stops spending energy on guessing. For the insurer this matters because the stress of adult employees shows up in the same portfolio: in claims for sick leave, in psychosomatic complaints and in long-term disability risk.

IV. The family benefit as a risk-management instrument

Offered as a corporate family benefit, a screening tool gives the parent clarity in ten minutes. The estimate used in this analysis is that such a benefit can reduce stress-related insured events among adult employees by 28%. It is a planning assumption: the real value will depend on take-up, the age of the children and the employer’s culture.

What the insurer and the broker receive in return can be set out in four points:

1. A preventive instrument that is inexpensive per child and easy to scale across a company.
2. A measurable link between family health and employee productivity, which can be tracked through absence data.
3. A retention argument for the corporate client: employees with young children value support that reduces uncertainty.
4. A differentiator in the broker’s own portfolio, based on risk reduction instead of on price.

Two cautions belong here. First, a screening tool is not a diagnosis, and it should never be presented as a replacement for a paediatrician. Its role is to show where attention is needed and to direct the family to the right specialist sooner. Second, the data of children and parents are sensitive. In Germany and in Poland any such programme must respect the GDPR (DSGVO in Germany, RODO in Poland), and the insurer should see aggregated, anonymised indicators rather than individual profiles.

V. Conclusion: where OkiTalki fits

OkiTalki is built for exactly this kind of use. A parent completes a screening of 36 questions in about ten minutes and receives a developmental profile of the child. Where the profile shows a point of attention, the parent is offered two-minute home micro-games for balance, coordination or hearing, which fit into an ordinary evening. Where more is needed, the profile gives the family a clear basis for a conversation with the kindergarten and the doctor.

In that sense the tool is a bridge between the family, the nursery or kindergarten and the medical system. For a health insurer, this bridge moves attention to an earlier and cheaper point in the chain of care. For a broker, it turns a standard package into a portfolio with a defensible risk-management argument. For an employer, it reduces the quiet cost of parental worry.

The sensible next step is a pilot: a defined group of employees, a defined period, and absence and claims data compared with a control group. The result will then speak for itself, in the form that insurers trust most.